Antiganglioside antibodies in neurological diseases
- 1 January 2020
- journal article
- review article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 408, 116576
Abstract
No abstract availableKeywords
This publication has 83 references indexed in Scilit:
- Nodo-paranodopathy: Beyond the demyelinating and axonal classification in anti-ganglioside antibody-mediated neuropathiesClinical Neurophysiology, 2013
- Multiple Cranial Neuropathies Without Limb Involvements: Guillain-Barre Syndrome Variant?Annals of Rehabilitation Medicine, 2013
- Anti-GD1a antibodies activate complement and calpain to injure distal motor nodes of Ranvier in miceBrain, 2010
- Pathophysiological actions of neuropathy‐related anti‐ganglioside antibodies at the neuromuscular junctionThe Journal of Physiology, 2009
- Antiganglioside antibodies and their pathophysiological effects on Guillain-Barre syndrome and related disorders--A reviewGlycobiology, 2009
- Anti-GM1 Antibodies Cause Complement-Mediated Disruption of Sodium Channel Clusters in Peripheral Motor Nerve FibersThe Journal of Neuroscience, 2007
- Antiganglioside antibodies in paraneoplastic peripheral neuropathiesJournal of Neurology, Neurosurgery & Psychiatry, 2004
- Normally Occurring Human Anti-GM1Immunoglobulin M Antibodies and the Immune Response to BacteriaInfection and Immunity, 2004
- Localization of major gangliosides in the PNS: implications for immune neuropathiesBrain, 2002
- Cryptogenic Partial Epilepsies with Anti‐GM1 Antibodies: A New Form of Immune‐Mediated Epilepsy?Epilepsia, 1996